Purchases and Sales Made in Q3 2022 in Lava Therapeutics Nv (LVTX)
This table provides information about the institutional ownership of Lava Therapeutics Nv (LVTX) during Q3 2022. The information is specifically focused on institutions that hold shares of LAVA Therapeutics NV.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 28, 2022
Q3 2022
|
Silverarc Capital Management, LLC
|
BUY
|
- |
611KNew |
$1.43M - $2.9M
|
611K
$635K
|
|
|
Nov 14, 2022
Q3 2022
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
- |
75KNew |
$176K - $356K
|
75K
$78K
|
|
|
Nov 14, 2022
Q3 2022
|
Cannell Capital LLC
Alta, WY |
BUY
|
- |
13.9K+ 342.46% |
$32.5K - $66K
|
18K
$18.7K
|
|
|
Nov 14, 2022
Q3 2022
|
Axa S.A.
Paris, I0 |
BUY
|
- |
1.2K+ 0.53% |
$2.8K - $5.69K
|
229K
$238K
|
|
|
Feb 14, 2023
Q3 2022
|
Axa S.A.
Paris, I0 |
BUY
|
- |
1.2K+ 0.53% |
$2.8K - $5.69K
|
229K
$238K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-700- 12.28% |
$1.64K - $3.33K
|
5K
$5.2K
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-57.2K- 59.38% |
$134K - $272K
|
39.2K
$40.7K
|